MYMD PHARMACEUTICALS INC's ticker is and the CUSIP is 62856X952. A total of 3 filers reported holding MYMD PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $466 | -94.0% | 1,800 | -86.4% | 0.00% | – |
Q3 2023 | $7,814 | +24.0% | 13,200 | +214.3% | 0.00% | – |
Q2 2023 | $6,300 | -70.7% | 4,200 | -66.4% | 0.00% | – |
Q1 2023 | $21,500 | +1599.6% | 12,500 | +1036.4% | 0.00% | – |
Q4 2022 | $1,265 | -57.8% | 1,100 | 0.0% | 0.00% | – |
Q3 2022 | $3,000 | – | 1,100 | +450.0% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 200 | -77.8% | 0.00% | – |
Q1 2022 | $4,000 | -50.0% | 900 | -30.8% | 0.00% | – |
Q4 2021 | $8,000 | +300.0% | 1,300 | +333.3% | 0.00% | – |
Q3 2021 | $2,000 | – | 300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
SIMPLEX TRADING, LLC | 5,700 | $34,000 | 0.00% |
GROUP ONE TRADING LLC | 1,300 | $8,000 | 0.00% |